Cargando…

The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia

Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Muro, Koji, Toda, Naohiro, Yamamoto, Shinya, Yanagita, Motoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946495/
https://www.ncbi.nlm.nih.gov/pubmed/32999232
http://dx.doi.org/10.2169/internalmedicine.5461-20
_version_ 1783663063088496640
author Muro, Koji
Toda, Naohiro
Yamamoto, Shinya
Yanagita, Motoko
author_facet Muro, Koji
Toda, Naohiro
Yamamoto, Shinya
Yanagita, Motoko
author_sort Muro, Koji
collection PubMed
description Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to treating such cases has not been established. We herein report a case of the successful treatment of HCV-associated cryoglobulinemic glomerulonephritis with rituximab, DAAs, occasional plasmapheresis and long-term steroid, with the patient's renal function and proteinuria improving over the long term despite serologically persistent cryoglobulinemia. This case suggests the efficacy of combination treatment with rituximab, DAAs, occasional plasmapheresis and long-term steroid for persistent cryoglobulinemia.
format Online
Article
Text
id pubmed-7946495
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-79464952021-03-15 The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia Muro, Koji Toda, Naohiro Yamamoto, Shinya Yanagita, Motoko Intern Med Case Report Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to treating such cases has not been established. We herein report a case of the successful treatment of HCV-associated cryoglobulinemic glomerulonephritis with rituximab, DAAs, occasional plasmapheresis and long-term steroid, with the patient's renal function and proteinuria improving over the long term despite serologically persistent cryoglobulinemia. This case suggests the efficacy of combination treatment with rituximab, DAAs, occasional plasmapheresis and long-term steroid for persistent cryoglobulinemia. The Japanese Society of Internal Medicine 2020-09-30 2021-02-15 /pmc/articles/PMC7946495/ /pubmed/32999232 http://dx.doi.org/10.2169/internalmedicine.5461-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Muro, Koji
Toda, Naohiro
Yamamoto, Shinya
Yanagita, Motoko
The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title_full The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title_fullStr The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title_full_unstemmed The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title_short The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
title_sort successful treatment of a case of hcv-associated cryoglobulinemic glomerulonephritis with rituximab, direct-acting antiviral agents, plasmapheresis and long-term steroid despite serologically persistent cryoglobulinemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946495/
https://www.ncbi.nlm.nih.gov/pubmed/32999232
http://dx.doi.org/10.2169/internalmedicine.5461-20
work_keys_str_mv AT murokoji thesuccessfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT todanaohiro thesuccessfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT yamamotoshinya thesuccessfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT yanagitamotoko thesuccessfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT murokoji successfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT todanaohiro successfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT yamamotoshinya successfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia
AT yanagitamotoko successfultreatmentofacaseofhcvassociatedcryoglobulinemicglomerulonephritiswithrituximabdirectactingantiviralagentsplasmapheresisandlongtermsteroiddespiteserologicallypersistentcryoglobulinemia